Page 18 - Technology Access Pool News Today

At current vaccination rate low income countries would be waiting 57 years for everyone to be fully vaccinated More than a million people have died from...

English News and Press Release on World about Health and Epidemic; published on 03 Jun 2021 by Oxfam

Seven Reasons the EU is Wrong to Oppose the TRIPS Waiver People wait to get tested for Covid-19 in Hyderabad, India, April 25, 2021.  © 2021 AP Photo/Mahesh Kumar A. As the Covid-19 pandemic has devastating human rights, social, and economic consequences across the globe, European Union (EU) representatives have repeatedly stated their commitment to the idea that Covid-19 vaccines should be a universal common good and that no one is safe from Covid-19 unless...

Yet the EU has consistently opposed India and South Africa's proposal at the World Trade Organization to temporarily waive certain intellectual property rules under the Agreement on Trade-Related Aspects of Intellectual Property Rights, a measure that would expand access to lifesaving vaccines and other health products. The arguments used by the...

Jayati Ghosh The decision by Joe Biden’s administration to stop opposing a proposed Covid-19 waiver of certain intellectual-property rights under World Trade Organization rules is a welcome move. The United States trade representative, Katherine Tai, acknowledges that ‘the extraordinary circumstances of the Covid-19 pandemic call for extraordinary measures’. While affirming that it ‘believes strongly in intellectual property protections’, the Biden administration ‘in service of endi...

There has been impressive progress on the vaccination front. Scientists have come up with multiple vaccines in record time. Unprecedented public and private financing has supported vaccine research, development and manufacturing scale-up.

English News and Press Release on World about Health and Epidemic; published on 31 May 2021 by WHO

A dangerous gap is emerging between richer and poorer nations' recovery, and the longer we wait to act, the costlier action becomes in human suffering and economic losses.

A small number of pharmaceutical companies with the support of developed country governments invested billions of dollars in research and development of COVID-19 vaccines, related medicines, and technologies including mRNA, DNA, RNA, viral vector, protein subunit and testing materials along with their production and distribution.

I do not think that the waiver will help us overcoming the current vaccine shortage. The first problem is that there is not enough infrastructure – manufacturing facilities, equipment, personnel – to expand vaccine production to the levels it should be at to meet pandemic demand. In this context, altering the intellectual property status quo does little – Ana Santos Rutschman, assistant professor at the Saint Louis University School of Law pointed out in a conversation with Lénárd S...